Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel D Buchanan

Showing results (141-150 of 299) with videos related to

Pageof 30
Sort By:
Familial Cancer|January 31, 2026
Germline MLH1 c.-42 C > T is a likely pathogenic variant predisposing to a reduced-penetrance/modified Lynch syndrome phenotype featuring MLH1-methylated cancersDaniel D Buchanan, Rocio Alvarez, Khalid Mahmood, et al.
American Journal of Epidemiology|October 12, 2017
Association of DNA Methylation-Based Biological Age With Health Risk Factors and Overall and Cause-Specific MortalityPierre-Antoine Dugué, Julie K Bassett, JiHoon E Joo, et al.
JNCI Cancer Spectrum|April 30, 2021
Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal CancerMark A Jenkins, Daniel D Buchanan, John Lai, et al.
Familial Cancer|December 8, 2023
Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X familyJames M Chan, Mark Clendenning, Sharelle Joseland, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2013
Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?Aung Ko Win, John L Hopper, Daniel D Buchanan, et al.
Journal of Gastroenterology and Hepatology|June 9, 2016
Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohortsDaniel D Buchanan, Mark Clendenning, Christophe Rosty, et al.
The Journal of Biological Chemistry|June 21, 2015
The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent mannerJoongho Shin, Azadeh Carr, Georgia A Corner, et al.
Cancer Communications (London, England)|June 11, 2026
<i>TGFBR1</i>*6A and Risk for Colorectal CancerAllan M Johansen, Julie T Ziegler, Kojo Agyemang, et al.
Familial Cancer|August 14, 2014
High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registryChristophe Rosty, Michael D Walsh, Noralane M Lindor, et al.
Annals of Surgical Oncology|January 30, 2013
Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriersAung Ko Win, Susan Parry, Bryan Parry, et al.
Pageof 30

Showing results (141-150 of 299) with videos related to

Sort By:
Pageof 30
Familial Cancer|January 31, 2026
Germline MLH1 c.-42 C > T is a likely pathogenic variant predisposing to a reduced-penetrance/modified Lynch syndrome phenotype featuring MLH1-methylated cancersDaniel D Buchanan, Rocio Alvarez, Khalid Mahmood, et al.
American Journal of Epidemiology|October 12, 2017
Association of DNA Methylation-Based Biological Age With Health Risk Factors and Overall and Cause-Specific MortalityPierre-Antoine Dugué, Julie K Bassett, JiHoon E Joo, et al.
JNCI Cancer Spectrum|April 30, 2021
Assessment of a Polygenic Risk Score for Colorectal Cancer to Predict Risk of Lynch Syndrome Colorectal CancerMark A Jenkins, Daniel D Buchanan, John Lai, et al.
Familial Cancer|December 8, 2023
Inherited BRCA1 and RNF43 pathogenic variants in a familial colorectal cancer type X familyJames M Chan, Mark Clendenning, Sharelle Joseland, et al.
European Journal of Cancer (Oxford, England : 1990)|February 26, 2013
Are the common genetic variants associated with colorectal cancer risk for DNA mismatch repair gene mutation carriers?Aung Ko Win, John L Hopper, Daniel D Buchanan, et al.
Journal of Gastroenterology and Hepatology|June 9, 2016
Tumor testing to identify lynch syndrome in two Australian colorectal cancer cohortsDaniel D Buchanan, Mark Clendenning, Christophe Rosty, et al.
The Journal of Biological Chemistry|June 21, 2015
The intestinal epithelial cell differentiation marker intestinal alkaline phosphatase (ALPi) is selectively induced by histone deacetylase inhibitors (HDACi) in colon cancer cells in a Kruppel-like factor 5 (KLF5)-dependent mannerJoongho Shin, Azadeh Carr, Georgia A Corner, et al.
Cancer Communications (London, England)|June 11, 2026
<i>TGFBR1</i>*6A and Risk for Colorectal CancerAllan M Johansen, Julie T Ziegler, Kojo Agyemang, et al.
Familial Cancer|August 14, 2014
High prevalence of mismatch repair deficiency in prostate cancers diagnosed in mismatch repair gene mutation carriers from the colon cancer family registryChristophe Rosty, Michael D Walsh, Noralane M Lindor, et al.
Annals of Surgical Oncology|January 30, 2013
Risk of metachronous colon cancer following surgery for rectal cancer in mismatch repair gene mutation carriersAung Ko Win, Susan Parry, Bryan Parry, et al.
Pageof 30